Primary Progressive Multiple Sclerosis Treatment Market to Rise at 14.7% CAGR during Forecast Period, 2022 TMR Study Wilmington, Delaware, United States, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global primary progressive multiple sclerosis treatment industry was worth US$ 828.4 Mn...

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis Collaboration in-line with Corbus vision to become the global leader in the treatment of inflammatory and fibrotic diseases by targeting the endocannabinoid systemAdvances strategy to partner...